{
    "2021-03-31": [
        [
            {
                "time": "",
                "original_text": "上市筹资，真的是强化分销渠道？",
                "features": {
                    "keywords": [
                        "上市",
                        "筹资",
                        "强化",
                        "分销渠道"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "里昂：上海医药(02607)业绩符合预期 评级“买入” 目标价降19.6%至19.32港元 盈利能力下降",
                "features": {
                    "keywords": [
                        "里昂",
                        "上海医药",
                        "业绩",
                        "买入",
                        "目标价",
                        "盈利能力",
                        "下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}